Cold Calling Your Way Into Venture Capital | Philip Borden (2/4)

🧬 The Biotech Startups Podcast is powered by Excedr: helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.

As a TBSP listener, you can get exclusive perks through Excedr's partner network: special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.

“What I could offer is I'm willing to work hard. I'm willing to learn. I'm willing to be a good contributor.”

Philip Borden explains how realizing he did not want to pursue a PhD or spend his career at the lab bench led him toward venture capital. With a molecular biology degree, limited finance experience, and a list of biotech VC firms, he picked up the phone and cold-called his way into Frazier Healthcare in Seattle.

Philip shares why personal relationships, phone calls, and in-person conversations matter more than email when building trust. He discusses selling as communication and listening, the humility required to ask for an opportunity, and the culture lessons he learned from working alongside experienced investors.

He also explains why investors owe founders timely, respectful answers, including a clear no. The conversation closes with the small customer rituals Labshares uses to honor entrepreneurs, from ribbon cuttings to creating a fun place to work.

Key Topics Covered:

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

Listen and subscribe to The Biotech Startups Podcast:

Apple Podcasts: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994

Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4

YouTube: https://www.youtube.com/@thebiotechstartupspodcast

Website: https://www.thebiotechstartupspodcast.com/

Find our guest, Philip Borden, at these links:

LinkedIn: https://www.linkedin.com/in/philipborden

Website: https://www.labshares.com/

Find our host, Jon Chee, at these links:

LinkedIn: https://www.linkedin.com/in/jonchee/

Learn more about Excedr:

LinkedIn: https://www.linkedin.com/company/excedr/

Website: https://www.excedr.com

Intro & Outro Songs Created by OkKyojin, Owned by Excedr:

Website: https://flow.page/kyojin

Resources & Articles:

Labshares About Us: https://www.labshares.com/about-us

Harvard Business School: https://www.hbs.edu/

Duke University: https://www.duke.edu/

University of Washington: https://www.washington.edu/

Amazon: https://www.amazon.com/

Companies, Universities, & People Mentioned:

Frazier Healthcare Partners: https://www.frazierhealthcare.com

Riverside Partners: https://www.riversidepartners.com

Galen Partners: https://www.galen-partners.com

Longfellow Healthcare Partners: https://www.longfellowhc.com

Duke University: https://www.duke.edu

Harvard Business School: https://www.hbs.edu

Amazon: https://www.amazon.com

Microsoft: https://www.microsoft.com

Moderna: https://www.modernatx.com

Alan Frazier: https://www.frazierhealthcare.com

Nader Naini: https://www.frazierhealthcare.com

Patrick Herron: https://www.frazierhealthcare.com

Örn Almarsson: https://www.linkedin.com/in/ornalmarsson

00:00 Intro

01:31 Choosing Not to Pursue Graduate School

03:40 Finding a Path Into Venture Capital

04:10 Cold-Calling Frazier Healthcare

04:54 Why the Phone Still Matters

06:49 Selling as Communication and Listening

08:10 Humility and the Frazier Culture

09:47 Moving to Seattle

11:57 Learning Through Partner Meetings

12:26 Screening Deals and Meeting Entrepreneurs

12:55 Respecting Founders in Vulnerable Moments

15:37 The Importance of Closing the Loop

18:30 Manufacturing Luck

19:04 Honoring Customers With Ribbon Cuttings

19:51 Outro

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.